Although the popular opioid, tramadol, may reduce chronic pain, it also significantly increases risk of serious side effects from chest pain to heart failure. The corresponding study was published in BMJ…
Category: 8. Health
-
Experimental Drug ‘NU-9’ Shows Promise Against Alzheimer’s
An experimental drug called NU-9 has shown promise as an early intervention for Alzheimer’s disease. The corresponding study was published in Alzheimer’s & Dementia.
“Alzheimer’s disease begins…
Continue Reading
-
Experimental Drug ‘NU-9’ Shows Promise Against Alzheimer’s
An experimental drug called NU-9 has shown promise as an early intervention for Alzheimer’s disease. The corresponding study was published in Alzheimer’s & Dementia.
“Alzheimer’s disease begins…
Continue Reading
-
Visual analog scale has comparable validity for perennial allergic, nonallergic rhinitis
The visual analog scale (VAS) demonstrates comparable validity for perennial allergic rhinitis (PAR) and nonallergic rhinitis (NAR) severity and quality-of-life (QoL) impairment, according to a study published online Dec. 23 in The Journal of…
Continue Reading
-
How to make and keep New Year's resolutions
Most New Year’s resolutions collapse before the holiday decorations reach the loft—and it’s not that people are lazy or necessarily lack motivation. The issue is that most goals are written in the tone of a stern headteacher, which is a fast…
Continue Reading
-
Understanding childhood obesity: Causes, treatments and how to reduce stigma
While childhood obesity has become more common in recent years, this is a condition that is about more than just weight.
Continue Reading
-
Exploring the occurrence of coal workers' pneumoconiosis-linked deaths
From 2020 to 2023, 1,754 decedents had coal workers’ pneumoconiosis (CWP) listed on their death certificates, according to research published in the Dec. 18 issue of the U.S. Centers for Disease Control and Prevention Morbidity and Mortality…
Continue Reading
-
Prescribing of some controlled medications has decreased in youth over past two decades
In the past two decades, there were decreases in prescribing of some controlled medications to adolescents and young adults, according to a study published online Dec. 15 in Drug and Alcohol Dependence.
Continue Reading
-
FDA approves Jascayd for progressive pulmonary fibrosis
The U.S. Food and Drug Administration has approved Jascayd (nerandomilast) tablets for the treatment of progressive pulmonary fibrosis in adults.
Continue Reading
-
Visiting abroad in the coming year? Antibiotics becoming less effective against traveler's diarrhea, study warns
Planning some international travel as one of your New Year’s resolutions?
Continue Reading